255 related articles for article (PubMed ID: 18267277)
21. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
Berg D
Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
[TBL] [Abstract][Full Text] [Related]
22. Transcranial sonography in the early and differential diagnosis of Parkinson's disease.
Berg D
J Neural Transm Suppl; 2006; (70):249-54. PubMed ID: 17017537
[TBL] [Abstract][Full Text] [Related]
23. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
López Hernández N; García Escrivá A; Shalabi Benavent M
Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
[TBL] [Abstract][Full Text] [Related]
25. Transcranial sonography in the discrimination of Parkinson's disease versus vascular parkinsonism.
Venegas-Francke P
Int Rev Neurobiol; 2010; 90():147-56. PubMed ID: 20692499
[TBL] [Abstract][Full Text] [Related]
26. Clinical criteria for the diagnosis of Parkinson's disease.
Reichmann H
Neurodegener Dis; 2010; 7(5):284-90. PubMed ID: 20616563
[TBL] [Abstract][Full Text] [Related]
27. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
[TBL] [Abstract][Full Text] [Related]
28. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.
Berg D; Merz B; Reiners K; Naumann M; Becker G
Mov Disord; 2005 Mar; 20(3):383-5. PubMed ID: 15486999
[TBL] [Abstract][Full Text] [Related]
29. [Methods for the early diagnosis of Parkinson's disease].
Becker G
Nervenarzt; 2003 Mar; 74 Suppl 1():S7-11. PubMed ID: 12624678
[TBL] [Abstract][Full Text] [Related]
30. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.
Walter U
J Neural Transm (Vienna); 2011 Apr; 118(4):607-12. PubMed ID: 21190047
[TBL] [Abstract][Full Text] [Related]
31. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Izawa MO; Miwa H; Kajimoto Y; Kondo T
Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
[TBL] [Abstract][Full Text] [Related]
32. Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.
Smajlovic D; Ibrahimagic OC
Med Arch; 2017 Aug; 71(4):261-264. PubMed ID: 28974846
[TBL] [Abstract][Full Text] [Related]
33. Transcranial sonography in relation to SPECT and MIBG.
Kajimoto Y; Miwa H; Kondo T
Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
[TBL] [Abstract][Full Text] [Related]
34. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.
Gaenslen A; Unmuth B; Godau J; Liepelt I; Di Santo A; Schweitzer KJ; Gasser T; Machulla HJ; Reimold M; Marek K; Berg D
Lancet Neurol; 2008 May; 7(5):417-24. PubMed ID: 18394965
[TBL] [Abstract][Full Text] [Related]
35. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
[TBL] [Abstract][Full Text] [Related]
36. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.
Walter U; Dressler D; Wolters A; Wittstock M; Benecke R
Mov Disord; 2007 Jan; 22(1):48-54. PubMed ID: 17083096
[TBL] [Abstract][Full Text] [Related]
37. Transcranial brain parenchyma sonography in movement disorders: state of the art.
Walter U; Behnke S; Eyding J; Niehaus L; Postert T; Seidel G; Berg D
Ultrasound Med Biol; 2007 Jan; 33(1):15-25. PubMed ID: 17189043
[TBL] [Abstract][Full Text] [Related]
38. Transcranial sonography in essential tremor.
Stockner H; Wurster I
Int Rev Neurobiol; 2010; 90():189-97. PubMed ID: 20692503
[TBL] [Abstract][Full Text] [Related]
39. Transcranial sonography findings related to non-motor features of Parkinson's disease.
Walter U; Skoloudík D; Berg D
J Neurol Sci; 2010 Feb; 289(1-2):123-7. PubMed ID: 19735925
[TBL] [Abstract][Full Text] [Related]
40. The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans.
Liu P; Li X; Li FF; Ou-Yang QH; Zhang HX; Feng T
Neurosci Lett; 2014 Oct; 582():99-103. PubMed ID: 25218716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
